首页|Verapamil enhances the sensitivity of oxaliplatin to tumor cells by influencing the PARP pathway
Verapamil enhances the sensitivity of oxaliplatin to tumor cells by influencing the PARP pathway
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Govi-Verlag Pharmazeutischer Verlag Gmbh
PARP is a DNA damage-modifying enzyme present in most eukaryotic cells. In this study, reverse docking showed that verapamil (Vera), which can effectively bind PARP1/2, could significantly inhibit PARP1/2 activity inside and outside the system. Moreover, it could enhance the sensitivityof oxaliplatin to low-expression P-glycoprotein (P-gP) tumor cells and strengthen its apoptosis-inducing effect on tumor cells under the reverse drug resistance concentration of tumor cells. Vera, which can reverse chemotherapy resistance of tumor cells, showed no simple correlations withoxaliplatin drug resistance or P-gP expression and could enhance the anti-tumor effect of platinum chemotherapeutic agents by influencing the PARP pathway.
NSTL
Govi-Verlag Pharmazeutischer Verlag Gmbh
